Showing results (291-300 of 645) with videos related to
Sort By:
Pageof 65
European Journal of Clinical Investigation|February 1, 1977
Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administrationD Collen, J Schetz, F de Cock, et al.Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
A fully functional deletion staphylokinase derivative crystallizes in two non-isomorphous monoclinic modificationsA Rabijns, H L De Bondt, D Collen, et al.Blood|March 26, 1999
Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.Thrombosis and Haemostasis|January 1, 1994
Prevalence and induction of circulating antibodies against recombinant staphylokinaseP J Declerck, S Vanderschueren, J Billiet, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.Circulation|July 1, 1991
Streptokinase-induced platelet aggregation. Prevalence and mechanismD E Vaughan, E Van Houtte, P J Declerck, et al.Thrombosis and Haemostasis|August 31, 1984
Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosisD Collen, J M Stassen, M Blaber, et al.The Journal of Biological Chemistry|August 26, 1998
NH2-terminal structural motifs in staphylokinase required for plasminogen activationB Schlott, K H Gührs, M Hartmann, et al.The Journal of Biological Chemistry|July 3, 1999
Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 geneH Ding, A M Benotmane, G Suske, et al.Thrombosis and Haemostasis|December 1, 1996
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.Pageof 65